Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Pharma
  4. Pharma — December 2023

Pharma — December 2023

Planlagt Fastgjort Låst Flyttet Pharma
20 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #4

    Efter en solid slutspurt endte de amerikanske aktier med pæne plusser trods stigende renter. Det ser dog mere trægt ud fredag i det amerikanske futuresmarked, hvor de ledende indeks falder en smule tilbage.
    Stemningen på de europæiske markeder er dog bedre, og det toneangivende tyske DAX-indeks indikeres op med 0,3 pct. inden åbningen.
    Efter opløftende inflationstal fra både eurozonen og USA er troen på, at inflationen kan komme ned omkring 2 pct. med det nuværende renteniveau, steget.

    1 Reply Last reply
    0
    • P Offline
      P Offline
      ProinvestorNEWS
      wrote on sidst redigeret af
      #5

      Derfor vil der også blive holdt skarpt øje med eftermiddagens tal fra den amerikanske centralbankchef, Jerome Powell. Flere af de regionale Federal Reserve-chefer har allerede indikeret, at den nuværende rente kan være tilstrækkelig. Spørgsmålet er så, om Jerome Powell vil gentage den retorik i sin tale, eller om han vil forsøge at dæmpe markedets forventninger.

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #6

        Råvarer
        Brent spot | +0,2% | 80,58 dollar
        WTI spot | +0,4% | 75,86 dollar
        Guld spot | +0,2% | 2039,81 dollar

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #7

          Valuta
          EURUSD | +0,2% | 1,0906 dollar
          USDJPY | -0,1% | 148,08 yen
          EURJPY | +0,1% | 161,53 yen
          GBPUSD | +0,1% | 1,2640 dollar

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #8

            Kilde: Nordnet

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #9

              Astellas' Veoza Approved In Europe For Treatment Of Vasomotor Symptoms Associated With Menopause https://www.proinvestor.com/investornyt/1088746/astellas-veoza-approved-in-europe-for-treatment-of-vasomotor-symptoms-associated-with-menopause

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #10

                Novartis : Phase III Trial Results Show Sustained Efficacy & Long-term Safety Of Fabhalta In PNH https://www.proinvestor.com/investornyt/1088751/novartis-phase-iii-trial-results-show-sustained-efficacy-amp-long-term-safety-of-fabhalta-in-pnh

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #11

                  AstraZeneca : Phase III Trial Data Show Danicopan Sustained Clinical Improvements In PNH https://www.proinvestor.com/investornyt/1088753/astrazeneca-phase-iii-trial-data-show-danicopan-sustained-clinical-improvements-in-pnh

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #12

                    Danske Bank ser opkøb som mulig bro over truende patentkløft for Lundbeck https://www.proinvestor.com/investornyt/1088791/danske-bank-ser-opkob-som-mulig-bro-over-truende-patentkloft-for-lundbeck

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #13

                      Sanofi Terminates Pompe Disease Drug Agreement With Maze Therapeutics Following FTC Opposition https://www.proinvestor.com/investornyt/1089315/sanofi-terminates-pompe-disease-drug-agreement-with-maze-therapeutics-following-ftc-opposition

                      1 Reply Last reply
                      0
                      • OccamO Offline
                        OccamO Offline
                        Occam
                        wrote on sidst redigeret af
                        #14

                        Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-all-required-regulatory-approvals-complete

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #15

                          Pfizer har øretæver i sigte efter skuffende prognose for næste år https://www.proinvestor.com/investornyt/1089999/pfizer-har-oretaever-i-sigte-efter-skuffende-prognose-for-naeste-ar

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #16

                            AbbVie (ABBV) Declines More Than Market: Some Information for Investors https://www.proinvestor.com/investornyt/1091670/abbvie-abbv-declines-more-than-market-some-information-for-investors

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              ProinvestorNEWS
                              wrote on sidst redigeret af
                              #17

                              Eli Lilly (LLY) Dips More Than Broader Market: What You Should Know https://www.proinvestor.com/investornyt/1091668/eli-lilly-lly-dips-more-than-broader-market-what-you-should-know

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                ProinvestorNEWS
                                wrote on sidst redigeret af
                                #18

                                ALK får lavere kursmål hos Kempen
                                22.12.2023 17.12 • MarketWire •
                                ALK-Abelló har fået reduceret kursmålet for aktien til 150 kr. fra 200 kr. hos Kempen.

                                Anbefalingen er uændret "køb".

                                Det fremgår af Bloomberg.

                                Aktien faldt fredag 0,3 pct. til 99 kr.

                                .\˙ MarketWire

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #19

                                  AstraZeneca To Buy Gracell For Up To $1.2 Bln https://www.proinvestor.com/investornyt/1095718/astrazeneca-to-buy-gracell-for-up-to-12-bln

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #20

                                    Bristol Myers Squibb To Acquire RayzeBio For $62.50/share In All-cash Deal https://www.proinvestor.com/investornyt/1095756/bristol-myers-squibb-to-acquire-rayzebio-for-6250-share-in-all-cash-deal

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #21

                                      Astrazeneca klar til at foretage et af de første opkøb i Kina https://www.proinvestor.com/investornyt/1096052/astrazeneca-klar-til-at-foretage-et-af-de-forste-opkob-i-kina

                                      1 Reply Last reply
                                      0

                                      Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                      Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                      With your input, this post could be even better 💗

                                      Tilmeld Log ind
                                      Svar
                                      • Svar som emne
                                      Login for at svare
                                      • Ældste til nyeste
                                      • Nyeste til ældste
                                      • Most Votes


                                      • Log ind

                                      • Har du ikke en konto? Tilmeld

                                      • Login or register to search.
                                      Powered by NodeBB Contributors
                                      • First post
                                        Last post
                                      0
                                      • Kategorier
                                      • Seneste
                                      • Etiketter
                                      • Populære
                                      • Verden
                                      • Bruger
                                      • Grupper